Pt. Roberts, WA and Delta, BC – April 18, 2017 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its affiliated directory www.420cannabisinvestorideas.com announce the most recent addition; The American Growth Fund Series Two (NASDAQ: AMREX).

Investorideas Featured Company: American Growth Fund Series Two (AMREX)

American Growth Fund Series Two (NASDAQ: AMREX), is currently the country’s only Cannabis Mutual Fund.  Headquartered in Denver, this diversified fund focuses solely on the cannabis industry.  Approved by the SEC, it invests in publicly traded companies in areas that support this exploding industry like pharmaceuticals, agriculture, hydroponic, equipment, to name a few.

Website URL: http://www.agfseries2.com/

Facebook: https://www.facebook.com/agfseries2/

Twitter: https://twitter.com/agfseries2

See more info and additional 420 listings on www.420cannabisinvestorideas.com

Timothy Taggart is the CEO of American Growth Fund Series Two (AMREX), currently the United States’ only Cannabis Mutual Fund.  Headquartered in Denver, this diversified fund focuses solely on the cannabis industry.  Approved by the SEC, it invests in publicly traded companies in areas that support the industry like pharmaceuticals, agriculture, hydroponic, equipment, to name a few. He’s been following recent week’s development and says this is a great time for the industry as a whole.

 “The legal cannabis industry is on the rise and does not seem to be slowing down. As the cannabis industry evolves we will see that some cannabis related stocks are not winners, but several of the examples that follow are a fairly good indication as to where the cannabis industry is headed. North American sales are projected to top $20.2 billion by 2021 and reach up to $50 billion in the next decade. I believe this to be true because we have seen some significant growth in several cannabis related stocks. Some of these stocks include (OTC: OWCP) which has seen a 248% growth YTD. OWCP has a cannabis based crème for Psoriasis.  Cara Therapeutics (NASDAQ: CARA) has seen a 103% growth YTD because they are developing a cannabis-based pharmaceutical product that relieves itching in pruritus patients.  They are also making headway in their medical trials with drugs related to chronic kidneys associated with pruritus. CARA not only has a 103% growth YTD but surged 15% in March according to the FMP globally market intelligence. Lastly, Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) is up 58% YTD. ZYNE has developed a CBD gel for people with epilepsy. This gel has proven to lower incidents of seizures in patients with epilepsy,” Taggart says.

Previous Investorideas.com interview with Timothy Taggart, CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis Mutual Fund in the US

https://www.youtube.com/edit?o=U&video_id=vcmQQPOjZDU

Learn more about how to submit your company: http://www.investorideas.com/420cannabisinvestorideas/

Watch The 420 Cannabis Investor Ideas Video: https://www.youtube.com/watch?v=e2zFezO580Y

About Investorideas.com – News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory www.420cannabisinvestorideas.com

Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin – Marijuana / Hemp Stocks – News and Trends in Green Investing

Global Cannabis Investing – features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

[embedded content]

More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire – a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Source: New feed